Neuralink is a brain chip new company founded by Mask. According to foreign media reports, with the continuous development of Neuralink's various layouts, the future operation is expected to usher in a major increase, and strive to increase by U...
Neuralink is a brain chip new company founded by Mask. According to foreign media reports, with the continuous development of Neuralink's various layouts, the future operation is expected to usher in a major increase, and strive to increase by US$1 billion in 2031.
Bloomberg and other foreign media reports that Neuralink recently announced to investors that the company will produce results in the brain interface field, with the goal of completing 20,000 brain interface implantation surgeries every year in the future, achieving a milestone of US$1 billion in 2031.
Neuralink said it will continue to invest in resource layout of brain interfaces, and plans to set up five large clinics in the next six years to perform brain interface implantation surgery. It mainly provides three products developed by Neuralink, including "Telepathy" that allows spinal cord injury or dysfunction patients to gain autonomy, "Blindsight" that helps blind people to see the light, and "Deep" that treats neurodegenerative diseases such as Parkinson's disease and incision.
Neuralink estimates that Telepathy will obtain the approval of the US supervisory agency in 2029 and be approved for commercial listing. It can perform 2,000 surgeries per year, with an annual revenue of up to $100 million. Blindsight is also expected to approve commercialization in 2030, with the increase in the number of surgeries to 10,000 surgeries per year, and promote annual revenue of over $500 million.
Extended reading: Neuralink is a pioneer, completing two brain-subber interface implantation surgery in a single day
